Our vision for our lead asset NOX-A12 remains clear: to secure approval for its use in glioblastoma patients through a strategic partnership with a pharmaceutical company, supported by ...
In a report released today, Vikram Purohit from Morgan Stanley maintained a Hold rating on Ascendis Pharma (ASND – Research Report), with a price target of $180.00. The company’s shares closed ...
MSD will have the exclusive right to develop and commercialize therapeutics derived from the collaboration. In return, Epitopea will receive an undisclosed upfront payment and is eligible for ...
Romaniuk concludes that public discourse cannot exist without transparency, reinforcing the need for the Model Spec and community engagement. "Ultimately, we believe in the intellectual freedom to ...
"I just want to be transparent with people," Spencer said of other platform logos appearing in future Xbox game trailers, "for shipping on Nintendo Switch, we’re gonna put that. For shipping on ...
Xbox boss Phil Spencer has said it will continue putting PlayStation and Nintendo logos in its trailers to be "transparent" ...
Elon Musk's DOGE has made many cuts that are disrupting basic functions of the federal government. President Trump and Musk have brushed off concerns over conflict of interest. NBC News' Garrett ...
05:51 – What Ben thinks pharma is doing wrong with regards to publication bias and the lack of transparency. 13:54 – What organisations Ben thinks are making a positive change in this area.
Tampere University has licensed a drug molecule intended for treating Epidermolysis Bullosa (EB), a group of rare and severe skin disorders, to Theravia, a pharmaceutical company headquartered in ...
LabVantage Pharma is the only pre-configured and pre-validated pharmaceutical LIMS in the world. This greatly lowers the deployment cost (85%) and time (75%) compared to a traditional LIMS ...
In the third part of her video interview with Pharma Commerce Editor Nicholas Saraceno, Laura Johnson, senior director of sales, life sciences, Loftware, discusses why the demand for supply chain ...
Pharma R&,D is being shaped by many issues – biological therapies, personalized medicine and clinical trial transparency to name a few. Briggs Morrison, Executive Vice President, Global ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback